Oracle stock slides as $100B capex fears mount; DeepValue report flags execution risk

What happened

Oracle shares declined on June 5, 2026, as investors grew wary of the company's escalating AI infrastructure spending, with projections that capex could reach $100 billion under the Stargate expansion. The DeepValue master report, which rates ORCL as 'WAIT' with a conviction of 4.0, underscores that Oracle's debt-funded buildout is producing negative free cash flow ($24.7B trailing) while only ~12% of its $552.6B RPO is scheduled for recognition in the next 12 months. This means the market is pricing in a faster monetization timeline than the filings support, raising the risk of dilution or project churn. The report's bear case, valued at $175 per share, becomes more probable if the next 10-Q does not show an improvement in near-term RPO conversion. The stock's rise to $230 still leaves no margin of safety given the heavy reliance on access to capital markets and sustained customer demand.

Implication

Long-term investors should wait for clear evidence that near-term RPO recognition re-accelerates (from ~12% to at least 20%) and that funding remains customer-backed rather than equity-backed. The current valuation (~40x P/E, 33x EV/EBITDA) leaves no room for execution missteps, and the $248B in new lease commitments over the next few years add fixed-cost risk. A re-assessment window of 3-6 months is warranted, with attractive entry only below $190. If the next 10-Q shows faster conversion or if Oracle demonstrates that large contracts are fully funded by customers, the bullish scenario could emerge. However, should the ATM be activated or the financing plan upsized, per-share value will compress and the bear scenario becomes the base case.

Thesis delta

The news article confirms and amplifies the key risk identified in the DeepValue report: that Oracle's debt-funded AI capex is outpacing its ability to convert contracted backlog into cash flow. This shifts the risk/reward further toward the bear case, as the market begins to reprice the probability of dilution or project delays. While the headline growth remains strong, the financing and execution overhang now dominates the narrative, making the wait rating more appropriate than ever.